These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14764994)

  • 1. Gene expression profiling of human cutaneous melanoma: are we there yet?
    Gershenwald JE; Bar-Eli M
    Cancer Biol Ther; 2004 Jan; 3(1):121-3. PubMed ID: 14764994
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians.
    Sominidi-Damodaran S; Pittelkow MR; Meves A
    Mayo Clin Proc; 2016 Aug; 91(8):1147-8. PubMed ID: 27492918
    [No Abstract]   [Full Text] [Related]  

  • 3. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
    Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
    Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced response of cell cycle and apoptosis regulators in melanoma.
    Murphy M; Phelps A; Swede H; Claffey K
    Int J Dermatol; 2012 Oct; 51(10):1263-7. PubMed ID: 22994674
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioinformatic Analysis of Gene Expression for Melanoma Treatment.
    Kawakami A; Fisher DE
    J Invest Dermatol; 2016 Dec; 136(12):2342-2344. PubMed ID: 27884291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miRNAs in the progression of malignant melanoma.
    Mueller DW; Bosserhoff AK
    Br J Cancer; 2009 Aug; 101(4):551-6. PubMed ID: 19638982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in melanoma: past results and future potential.
    Knackstedt RW; Knackstedt T; Gastman B
    Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on Post-Publication Discussion of "Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma".
    Cook RW; Goldberg MS
    Ann Surg Oncol; 2022 Aug; 29(8):5239-5240. PubMed ID: 35380310
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
    Wu CE; Esfandiari A; Ho YH; Wang N; Mahdi AK; Aptullahoglu E; Lovat P; Lunec J
    Br J Cancer; 2018 Feb; 118(4):495-508. PubMed ID: 29235570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The plasma membrane Ca
    Hegedũs L; Garay T; Molnár E; Varga K; Bilecz Á; Török S; Padányi R; Pászty K; Wolf M; Grusch M; Kállay E; Döme B; Berger W; Hegedũs B; Enyedi A
    Int J Cancer; 2017 Jun; 140(12):2758-2770. PubMed ID: 27813079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines.
    Venza M; Dell'Aversana C; Visalli M; Altucci L; Teti D; Venza I
    Tumori; 2014; 100(1):e4-7. PubMed ID: 24675509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma progression, gene expression and DNA microarrays.
    Hoek KS
    G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Gene Expression Profiling on Decision-Making in Clinically Node Negative Melanoma Patients after Surgical Staging.
    Schuitevoerder D; Heath M; Cook RW; Covington KR; Fortino J; Leachman S; Vetto JT
    J Drugs Dermatol; 2018 Feb; 17(2):196-199. PubMed ID: 29462228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA arrays and the enigma of melanoma immune responsiveness.
    Wang E; Marincola FM
    Cancer J; 2001; 7(1):16-24. PubMed ID: 11269643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin.
    Cheng SL; Liu RH; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
    J Biomed Sci; 2007 Jan; 14(1):87-105. PubMed ID: 17103032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
    Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
    BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of gene expression profile testing as a prognostic tool in early-stage cutaneous melanoma - compelling but not ready for primetime.
    Christensen L; Scott J; Bordeaux J
    Melanoma Res; 2018 Dec; 28(6):652-654. PubMed ID: 30211811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.